Company Research Report: ARISTA Biotech Pte. Ltd.
Company Overview
- Name: ARISTA Biotech Pte. Ltd.
- Mission: Creating access to innovative and affordable products and technology, strategic advice, and data analytics in the management of the COVID-19 pandemic.
- Founded: No information is available.
- Founders: No information is available.
- Key People:
- Dr. Gary Wong - Australia
- Dr. Nathan Yim - Australia
- Mr. Gunther Wenzel - Germany
- Mr. Jimmy Tan - Malaysia
- Dr. Richard Fong - Thailand
- Mr. Phil Cody - United Kingdom
- Headquarters: 190 Middle Road, #16-01 Fortune Centre, 188979, Singapore
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: ARISTA is known for its COVID-19 diagnostic test kits and data analytics in managing the pandemic.
Products
ARISTA™ COVID-19 Antigen Rapid Test
- Description: A rapid test capable of detecting SARS-CoV-2 virus variants, including all major strains and emerging variants like Omicron BA.4 and BA.5.
- Key Features:
- Detects variants such as Alpha, Beta, Delta, Epsilon, Gamma, Lambda, and Omicron.
- High sensitivity similar to that against the original virus.
Viva Life App
- Description: An application designed for creating verifiable digital health certificates and storing ARISTA diagnostic test records.
- Key Features:
- Digital certification and secure record storage.
- Simplifies access to test information.
Viva Life Enterprise Account
- Description: A dashboard to manage enterprise safety programs and oversee test statuses.
- Key Features:
- Compatible with the Viva Life App to sync test records to organization dashboards.
- Facilitates management of enterprise safety and testing programs.
Recent Developments
- Recent Developments:
- Confirmation of the ARISTA™ COVID-19 Antigen Rapid Test’s sensitivity against the Omicron sub-lineages BA.4 and BA.5.
- Product authorization for use in South Africa and availability for use in China.
- Successful registration in Indonesia and Thailand.
- New Products Launched: No information is available.
- New Features Added to Existing Products:
- Continuous updates to detect emerging COVID-19 variants.
- New Partnerships:
- Regional distribution partnerships with entities in Australia, Germany, Malaysia, Thailand, and the United Kingdom.
This comprehensive report provides an insight into ARISTA Biotech’s COVID-related products, its strategic role in combating the pandemic, and its global operational presence through strategic partnerships and regional offices.